LSL Pharma Group Inc. (TSXV:LSL)
Canada · Delayed Price · Currency is CAD 0.2950
-0.0050 (-1.67%)
Oct 9, 2026, 3:29 PM EST
LSL Pharma Group Market Cap
LSL Pharma Group has a market cap or net worth of CAD 37.39 million as of October 9, 2026. It is the 35,148th most valuable company in the world and the 1,073rd biggest in Canada. Its market cap has decreased by 15.50% in one year.
Market Cap
37.39M
Enterprise Value
87.01M
Revenue
41.83M
Global Rank
Country Rank
#1,073 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since March 2, 2023, LSL Pharma Group's market cap has decreased from 61.67M to 37.39M, a decrease of -39.38%. That is a compound annual growth rate of -12.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 37.39M | -11.88% |
| Dec 31, 2025 | 42.43M | -10.43% |
| Dec 31, 2024 | 47.37M | 18.48% |
| Dec 29, 2023 | 39.98M | -35.17% |
| Mar 2, 2023 | 61.67M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Planet 13 Holdings | 51.97M |
| ZYUS Life Sciences | 48.31M |
| BioNxt Solutions | 44.91M |
| iAnthus Capital Holdings | 34.87M |
| Optimi Health | 33.15M |
| Medicure | 31.10M |
| MediPharm Labs | 29.90M |
| Rubicon Organics | 29.73M |